Wedge Capital Management L L P NC Sells 77,367 Shares of Danaher Corporation (DHR)

Wedge Capital Management L L P NC lowered its position in shares of Danaher Corporation (NYSE:DHR) by 14.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 456,185 shares of the conglomerate’s stock after selling 77,367 shares during the quarter. Wedge Capital Management L L P NC owned about 0.07% of Danaher Corporation worth $38,497,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Lee Danner & Bass Inc. lifted its position in Danaher Corporation by 0.4% during the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock valued at $225,000 after buying an additional 10 shares during the period. Norway Savings Bank lifted its position in Danaher Corporation by 0.4% during the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after buying an additional 10 shares during the period. First Financial Corp IN lifted its position in Danaher Corporation by 0.8% during the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after buying an additional 21 shares during the period. Guardian Life Insurance Co. of America lifted its position in Danaher Corporation by 1.0% during the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after buying an additional 24 shares during the period. Finally, Assetmark Inc. lifted its position in Danaher Corporation by 0.5% during the first quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock valued at $566,000 after buying an additional 30 shares during the period. 75.68% of the stock is owned by institutional investors and hedge funds.

Danaher Corporation (NYSE:DHR) opened at 88.11 on Tuesday. The company has a market capitalization of $61.21 billion, a P/E ratio of 28.12 and a beta of 1.03. Danaher Corporation has a one year low of $75.71 and a one year high of $88.59. The stock’s 50 day moving average price is $82.84 and its 200 day moving average price is $84.20.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.90 EPS. Equities analysts anticipate that Danaher Corporation will post $3.95 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is currently 17.83%.

In other Danaher Corporation news, insider William King sold 7,458 shares of the stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares in the company, valued at $1,513,787.65. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the sale, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock valued at $5,916,223 over the last 90 days. 12.20% of the stock is currently owned by company insiders.

Several equities analysts have commented on the company. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Credit Suisse Group reissued a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research report on Wednesday, May 24th. Finally, Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $92.72.

TRADEMARK VIOLATION NOTICE: “Wedge Capital Management L L P NC Sells 77,367 Shares of Danaher Corporation (DHR)” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.chaffeybreeze.com/2017/09/19/wedge-capital-management-l-l-p-nc-sells-77367-shares-of-danaher-corporation-dhr.html.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply